Stay updated on Masitinib Efficacy and Safety in ALS Clinical Trial
Sign up to get notified when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.

Latest updates to the Masitinib Efficacy and Safety in ALS Clinical Trial page
- Check6 days agoChange DetectedA new entry for Malmö, Sweden has been added to the study's locations, and the previous Malmo, Sweden entry has been removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s displayed site software/version revision was updated from v3.5.2 to v3.5.3. This indicates a technical or platform update rather than a change to the clinical trial information.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check35 days agoChange DetectedThe Italian location name was updated from Padua, Italy to Padova, Italy in the Locations section. This reflects the native Italian naming of the city.SummaryDifference0.0%

- Check56 days agoChange DetectedA new revision v3.5.0 is shown, and revision v3.4.3 is removed.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Masitinib Efficacy and Safety in ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.